Experienced in Lung Cancer

Dr. Charles E. Bowers

Hematology Oncology
380 Serpentine Dr, 
Spartanburg, SC 
Experienced in Lung Cancer
380 Serpentine Dr, 
Spartanburg, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Charles Bowers is a Hematologist Oncology provider in Spartanburg, South Carolina. Dr. Bowers is rated as an Experienced provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Specialist in SC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

380 Serpentine Dr, Spartanburg, SC 29303

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Intergroup Randomized Phase 2 Four Arm Study In Patients ≥ 60 With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB → R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV→ R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB → LR) or Arm D = Rituximab + Bendamustine + Bortezomib Followed By Lenalidomide + Rituximab Consolidation (RBV → LR)
Intergroup Randomized Phase 2 Four Arm Study In Patients ≥ 60 With Previously Untreated Mantle Cell Lymphoma Of Therapy With: Arm A = Rituximab+ Bendamustine Followed By Rituximab Consolidation (RB → R); Arm B = Rituximab + Bendamustine + Bortezomib Followed By Rituximab Consolidation (RBV→ R), Arm C = Rituximab + Bendamustine Followed By Lenalidomide + Rituximab Consolidation (RB → LR) or Arm D = Rituximab + Bendamustine + Bortezomib Followed By Lenalidomide + Rituximab Consolidation (RBV → LR)
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2025
Intervention Type: Drug, Biological
Study Drugs: Rituximab, Bendamustine Hydrochloride, Bortezomib, Lenalidomide
Study Phase: Phase 2
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Phase III Randomized Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin &Amp; Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age >/= 60 Years)
Enrollment Status: Completed
Publish Date: December 13, 2024
Intervention Type: Drug, Other, Procedure
Study Drugs: Clofarabine, Daunorubicin, Cytarabine, Decitabine
Study Phase: Phase 3
Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
Enrollment Status: Completed
Publish Date: December 01, 2021
Intervention Type: Drug, Radiation
Study Drugs: Doxorubicin, Bleomycin, Vinblastine, Dacarbazine, Etoposide, Cyclophosphamide, Vincristine, Procarbazine, Prednisone
Study Phase: Phase 2
View 2 Less Clinical Trials
Similar Doctors
Distinguished in Lung Cancer
Dr. Britt H. Bolemon
Hematology Oncology | Hematology | Oncology
Distinguished in Lung Cancer
Dr. Britt H. Bolemon
Hematology Oncology | Hematology | Oncology

Prisma Health University Medical Group

210 Freeman Farm Rd, 
Duncan, SC 
 (14.1 miles away)
864-968-5123
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Britt Bolemon is a Hematologist Oncology specialist and a Hematologist in Duncan, South Carolina. Dr. Bolemon is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Lung Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Bolemon is currently accepting new patients.

Distinguished in Lung Cancer
Dr. Abderrahim Khomani
Oncology | Hematology Oncology
Distinguished in Lung Cancer
Dr. Abderrahim Khomani
Oncology | Hematology Oncology
101 E Wood St, 
Spartanburg, SC 
 (0.2 miles away)
864-560-7050
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Abderrahim Khomani is an Oncologist and a Hematologist Oncology provider in Spartanburg, South Carolina. Dr. Khomani is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Khomani is currently accepting new patients.

Distinguished in Lung Cancer
Dr. Carla W. Jorgensen
Oncology | Hematology Oncology | Hematology
Distinguished in Lung Cancer
Dr. Carla W. Jorgensen
Oncology | Hematology Oncology | Hematology

Prisma Health University Medical Group

3 Butternut Dr, Suite B, 
Greenville, SC 
 (29.3 miles away)
864-241-7272
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carla Jorgensen is an Oncologist and a Hematologist Oncology provider in Greenville, South Carolina. Dr. Jorgensen is rated as a Distinguished provider by MediFind in the treatment of Lung Cancer. Her top areas of expertise are Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Small Cell Lung Cancer (SCLC). Dr. Jorgensen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bowers's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile